Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Field
-
been linked to these diseases for decades. This project aims to establish human autoantibody clones from various autoimmune diseases, with a primary focus on Systemic Sclerosis. This is with the purpose
-
and Master's theses and doctoral students Your qualifications: Completed university degree (diploma or master's degree) in the field of chemistry, biochemistry or comparable, doctorate is an advantage
-
). This position is full-time, in person at the main campus in Memphis, TN. To apply, please send a cover letter describing your research interests and career goals, your CV, and contact information for 3 references
-
and implementing cutting-edge CRISPR/Cas9 approaches in primary human hematopoietic progenitors to evaluate gene functions and the effect of genetic variants in blood cells, including platelets and
-
designed to ensure equal opportunities. The primary criteria for selection will be the alignment of the applicant's existing skills and expertise with the requirements mentioned above.
-
Postdoctoral Research Associate - Training in Pediatric Cancer Survivorship Outcomes and Interventio
research studies, St. Jude LIFE and the Childhood Cancer Survivor Study (CCSS). Other benefits include: Access to exceptional core facilities to help advance your research. Opportunity to obtain a Master of
-
based Bachelor and Masters students and visiting staff and students, who together contribute to an international research environment where English is the preferred language in the laboratory, at meetings
-
and how their disruption contributes to altered auditory perception. Duties We are seeking a highly motivated Computational Biologist at the postdoctoral level to join our team. The primary
-
influence of various binder systems at elevated temperatures. The successful candidate will be responsible for: Developing an experimental strategy to investigate the main parameters influencing
-
-tumor immunity. Our lab's primary interest lies in understanding how T-cell signaling pathways influence cancer progression, with the goal of identifying and developing novel immunotherapies. We aim